PharmaShots | Incisive News in 3 Shots

Subscribe Now

EORTC1325

Merck's Keytruda (pembrolizumab) Receives EU Approval for Resected Stage III Melanoma in Adults

Merck's Keytruda (pembrolizumab) Receives EU Approval for Resected Stage III Melanoma in Adults

December 18, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us